Anticancer Alkaloids: Molecular Mechanisms and Clinical Manifestations
Emerging Alkaloids against Cancer: A peep into factors, regulation and molecular mechanisms
Mechanistic Insight into Cancer Etiology and Therapeutic Management by Natural Metabolites
Flavones: Flavonoids Having Chemico-Biological Properties With A Preview Into Anti-Cancer Action Mechanism
Cancer Chemoprevention by Dietary Polyphenols, Flavonoids, Terpenoids, and Saponins
Immunogenic Potential of Natural Products
Immunomodulatory and therapeutic potential of marine flora products in the treatment of cancer
Ligand-Based designing of natural products
Drug Resistance in Cancer and Role of Nanomedicine Based Natural Products.
This book illustrates the importance of the Natural Biometabolites, which offer a rich reservoir of candidate compounds for drug discovery in the battle against cancer. Recent research and development efforts concerning anti-cancer drugs derived from natural products have led to the identification of numerous candidate molecules that inhibit cancer cell proliferation and metastasis using a variety of mechanisms.
Given its scope, the book offers a valuable resource for cancer biologists and general oncologists alike, while also benefitting research professionals in Science, Nursing, Medicine, Biochemistry, Genetics and Bioscience who wish to understand the fundamentals of prognosis and prediction in tumorigenesis. Moreover, the book provides an essential platform for understanding drug resistance mechanisms and combatting the growing menace of multidrug resistance.
• The book comprehensively provide the recent updates on Natural metabolites and their therapeutics use against Cancer
• It summarize the distinctive pathways and mechanistic insight into the mode of action of Natural metabolites
• It highlights the utilization of nanoparticle-augmented Adjuvant therapy to enhance Pharmacodynamic and Pharmacokinetic Potency of Natural metabolites
• It elucidates designing of Ligand-based Drug from the Natural metabolites to enhance their active potential and counter adverse side effects
Dr. Anil K Sharma is presently at M.M. (DU), Department of Biotechnology, Mullana, Ambala (India), where he has been a Professor and Head of the Department since April 2012. Previously, he worked as a Senior Research Scientist in Health Sciences (UIC Chicago, USA; 2008-2010), Postdoctoral Research Fellow in Molecular Biology (Micro and Immunology Department, UIC Chicago, IL, USA; 2003-2008), and Senior Research Scientist at Ranbaxy (R&D, Gurgaon, Haryana, India; 2001-2003). He has authored more than 95 publications in peer-reviewed journals and received many prestigious awards and accolades including an Eminent Scientist Award for Molecular & Microbial Science (2017 & 2018), National Achiever Award (2016), and Bharat Excellence Award (2013). In addition to editing five books, he has been the Editor-in-Chief of two journals, and lead guest editor, editorial board member or reviewer of over 30 more.